{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:46:32Z","timestamp":1773294392608,"version":"3.50.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/jcp.0b013e31819b95fc","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:53:34Z","timestamp":1242910414000},"page":"109-116","source":"Crossref","is-referenced-by-count":21,"title":["Hormonal Markers of Metabolic Dysregulation in Patients With Severe Mental Disorders After Olanzapine Treatment Under Real-Life Conditions"],"prefix":"10.1097","volume":"29","author":[{"given":"Astrid B.","family":"Birkenaes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e5re I.","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svein","family":"Friis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein","family":"Opjordsmoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210128","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature.","volume":"62","author":"Allison","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes.","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S1092852900026663","article-title":"Metabolic findings from the CATIE trial and their relation to tolerability.","volume":"11","author":"Nasrallah","year":"2006","journal-title":"CNS Spectr"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2337\/diabetes.54.3.862","article-title":"Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.","volume":"54","author":"Ader","year":"2005","journal-title":"Diabetes"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/070674370204700805","article-title":"Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?","volume":"47","author":"Baptista","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin and adiponectin.","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr Res"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamus AMP-kinase.","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review.","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr Res"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1373\/clinchem.2004.032482","article-title":"Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.","volume":"50","author":"Meier","year":"2004","journal-title":"Clin Chem"},{"key":"R13-2-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin-a key adipokine in the metabolic syndrome.","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"R14-2-20210128","first-page":"275","article-title":"Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes.","volume":"76","author":"Birkeland","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-2-20210128","first-page":"290","article-title":"Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.","volume":"17","author":"Cikim","year":"2004","journal-title":"Diabetes Nutr Metab"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.ijo.0801285","article-title":"Neuroendocrine abnormalities in visceral obesity.","volume":"24","author":"Bjorntorp","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archpsyc.55.11.995","article-title":"Dose-dependent cortisol-induced increases in plasma leptin concentrations in healthy humans.","volume":"55","author":"Newcomer","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose and elevation of cortisol in drug-naive first-episode schizophrenia.","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R20-2-20210128","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/sj.npp.1301392","article-title":"Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients.","volume":"32","author":"Haupt","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R21-2-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2000-8451","article-title":"Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones.","volume":"33","author":"Baptista","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"R22-2-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-2001-18034","article-title":"Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration.","volume":"34","author":"Baptista","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R23-2-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/YIC.0b013e328080ca44","article-title":"Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia.","volume":"22","author":"Baptista","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R24-2-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.162.1.118","article-title":"Effect of OLZ on body composition and energy expenditure in adults with first-episode psychosis.","volume":"162","author":"Graham","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R25-2-20210128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.npp.1300563","article-title":"Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.","volume":"30","author":"Haupt","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R26-2-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R27-2-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v62n1102","article-title":"Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.","volume":"62","author":"Hagg","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R28-2-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130000639","article-title":"Insulin and leptin levels in patients with schizophrenia or related psychoses-a comparison between different antipsychotic agents.","volume":"154","author":"Melkersson","year":"2001","journal-title":"Psychopharmacology"},{"key":"R29-2-20210128","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4088\/JCP.v68n1202","article-title":"Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.","volume":"68","author":"Mei Bai","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R30-2-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","article-title":"Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia.","volume":"26","author":"Richards","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R31-2-20210128","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.pnpbp.2008.05.013","article-title":"Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine.","volume":"32","author":"Tanaka","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R32-2-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004714-200112000-00006","article-title":"The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.","volume":"21","author":"Scheepers","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R33-2-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pnpbp.2006.10.007","article-title":"The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.","volume":"31","author":"Jakovljevic","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R34-2-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology"},{"key":"R35-2-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YIC.0b013e32801182e6","article-title":"Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.","volume":"22","author":"Baptista","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R36-2-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/070674370605100310","article-title":"Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.","volume":"51","author":"Baptista","year":"2006","journal-title":"Can J Psychiatry"},{"key":"R37-2-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenia patients.","volume":"333","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"R38-2-20210128","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4088\/JCP.v68n0614","article-title":"The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia. A comparative study.","volume":"68","author":"Birkenaes","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R39-2-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2007.01.015","article-title":"A clinical study of the association of antipsychotics with hyperlipidemia.","volume":"92","author":"De Leon","year":"2007","journal-title":"Schizophr Res"},{"key":"R41-2-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R42-2-20210128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ajcn\/75.4.683","article-title":"Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat.","volume":"75","author":"Janssen","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R43-2-20210128","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant.","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"R44-2-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentration in man.","volume":"28","author":"Mathews","year":"1985","journal-title":"Diabetologia"},{"key":"R45-2-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","article-title":"Dyslipidemia independent of body mass in antipsychotic treated patients under real life conditions.","volume":"28","author":"Birkenaes","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R46-2-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","article-title":"Abnormalities in glucose regulation during antipsychotic treatment in schizophrenia.","volume":"59","author":"Newcomer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R47-2-20210128","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.npp.1301541","article-title":"Effects of olanzapine and ziprazidone on glucose tolerance in healthy controls.","volume":"33","author":"Sacher","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R48-2-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm1540","article-title":"Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins.","volume":"13","author":"Lam","year":"2007","journal-title":"Nat Med"},{"key":"R49-2-20210128","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/nm1202-798","article-title":"Hypothalamic insulin signalling is required for inhibition of glucose production.","volume":"8","author":"Obici","year":"2002","journal-title":"Nat Med"},{"key":"R50-2-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.ijo.0801467","article-title":"A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) obesity.","volume":"25","author":"Soderberg","year":"2001","journal-title":"Int J Obes"},{"key":"R51-2-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature"},{"key":"R52-2-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.1104344","article-title":"Diabetes, obesity, and the brain.","volume":"307","author":"Schwartz","year":"2005","journal-title":"Science"},{"key":"R53-2-20210128","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4088\/JCP.v67n1219","article-title":"Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.","volume":"67","author":"Raeder","year":"2006","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200904000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:13:57Z","timestamp":1618035237000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200904000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31819b95fc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}